Shirley Kuhlmann | General Counsel |
Joe Ciaffoni | Chief Executive Officer |
Scott Dreyer | Chief Commercial Officer |
Paul Brannelly | Chief Financial Officer |
David Amsellem | Piper Jaffray |
Brandon Folkes | Cantor Fitzgerald |
Ken Trbovich | Janney |
Serge Belanger | Needham & Company |
David Steinberg | Jefferies |
Tim Lugo | William Blair |
Kevin Kedra | Gabelli |
Good day, ladies and gentlemen, and welcome to the Q2 2018 Collegium Pharmaceutical, Inc. Earnings Conference Call. At this time, all participants are in a listen-only model. [Operator Instructions]. I would now like to turn the call over to Shirley Kuhlmann, General Counsel.